Cargando…

The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study—a study protocol for a randomized controlled trial

BACKGROUND: Age-related macular degeneration (AMD) is an irreversible blinding eye condition with complex genetic and environmental etiologies. Genetic testing for AMD for previously identified multiple-risk single nucleotide polymorphisms can help determine an individual’s future susceptibility. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Addo, Emmanuel K., Hartnett, M. Elizabeth, Bernstein, Paul S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278319/ https://www.ncbi.nlm.nih.gov/pubmed/37337222 http://dx.doi.org/10.1186/s13063-023-07436-4

Ejemplares similares

MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing
por: Rayes, Nadine, et al.
Publicado: (2019)

Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol
por: Crowther, Caroline A, et al.
Publicado: (2013)

Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management
por: Amini, Mohammad Amin, et al.
Publicado: (2023)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020)

Analysis of genetic polymorphisms for age-related macular degeneration (AMD) in Chinese Tujia ethnic minority group
por: Liu, Shengchun, et al.
Publicado: (2019)

Hands-On Music Generation with Magenta
por: DuBreuil, Alexandre
Publicado: (2020)

The role of lipocalin-2 in age-related macular degeneration (AMD)
por: Ghosh, Sayan, et al.
Publicado: (2020)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration
por: Hollitt, Georgina L, et al.
Publicado: (2023)

Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study
por: Ward, Elizabeth, et al.
Publicado: (2020)

Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD
por: Bhuiyan, Alauddin, et al.
Publicado: (2020)

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
por: Hernández-Zimbrón, Luis Fernando, et al.
Publicado: (2018)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
por: Choubey, Mayank, et al.
Publicado: (2023)

ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
por: Liakopoulos, Sandra, et al.
Publicado: (2020)

Fluctuating Selection in the Moran
por: Dean, Antony M., et al.
Publicado: (2017)

Unleashing your musical creativity with Magenta.js
por: Dinculescu, Monica
Publicado: (2019)

Green, Blue, Magenta, and Other Coloured Urines
por: Murrell, William, et al.
Publicado: (1906)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji, Tsuyoshi, et al.
Publicado: (2013)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021)

Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
por: Nashine, Sonali, et al.
Publicado: (2022)

Effect of Reading Rehabilitation for Age-Related Macular Degeneration on Cognitive Functioning: Protocol for a Nonrandomized Pre-Post Intervention Study
por: Wittich, Walter, et al.
Publicado: (2021)

Lifestyle Intervention Randomized Controlled Trial for Age-Related Macular Degeneration (AMD-Life): Study Design
por: de Koning-Backus, Alexandra P. M., et al.
Publicado: (2023)

Las campanas de Moran
por: Díaz Arcia, Pedro
Publicado: (1986)

Premio Diana Morán : poesía, cuento, ensayo.
Publicado: (1990)

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
por: Varano, Monica, et al.
Publicado: (2015)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

El movimiento sindical pintado de magenta : productividad, sexismo y neocorporativismo /
por: Solís de Alba, Ana Alicia
Publicado: (2002)

Prenatal Carotenoid Supplementation With Lutein or Zeaxanthin Ameliorates Oxygen-Induced Retinopathy (OIR) in Bco2(−/−) Macular Pigment Mice
por: Arunkumar, Ranganathan, et al.
Publicado: (2023)

Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD
por: Wyględowska-Promieńska, Dorota, et al.
Publicado: (2015)

What effects has the cataract surgery on the development and progression of Age-Related Macular Degeneration (AMD)?
por: Bockelbrink, Angelina, et al.
Publicado: (2006)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
por: Pennington, Katie L., et al.
Publicado: (2016)

Role of Mitochondrial DNA Damage in ROS-Mediated Pathogenesis of Age-Related Macular Degeneration (AMD)
por: Kaarniranta, Kai, et al.
Publicado: (2019)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
por: Hudson, Natalie, et al.
Publicado: (2020)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
por: Kauppinen, Anu, et al.
Publicado: (2020)

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
por: Sarkar, Aira, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bhn1tgkah1gf2v8206fkdi4lp0